October 31, 2014 9:36 AM ET

Healthcare Equipment and Supplies

Company Overview of Debiotech S.A.

Company Overview

Debiotech S.A. engages in the research and development of medical devices for therapeutic and diagnostic purposes. The company offers electronic infusion systems, drug delivery devices, microsystems, and diagnostics products. Its products include disposable programmable micro pumps, miniaturized infusion pumps, contrast media injectors, drug reconstitution devices, cyclers for peritoneal dialysis, flow regulators, and nano delivery systems. The company offers its products through medical devices and pharmaceutical companies. Debiotech S.A. was founded in 1990 and is based in Lausanne, Switzerland.

Le Portique

Avenue de Sévelin 28

Lausanne,  1004

Switzerland

Founded in 1990

Phone:

41 21 623 60 00

Fax:

41 21 623 60 01

Key Executives for Debiotech S.A.

Chief Executive Officer
Compensation as of Fiscal Year 2014.

Debiotech S.A. Key Developments

Debiotech to Introduce New Insulin JewelPUMP2 for Diabetes Type 2 During the 2014 ATTD Conference in Vienna, Austria

Debiotech S.A. announced that JewelPUMP2, which will be unveiled for the first time at the ATTD 2014 congress on February 5(th) in Vienna, is a new product dedicated to the Diabetes Type 2 market, based on Debiotech's innovative JewelPUMP platform. The JewelPUMP2 has been entirely re-designed to address the very specific market of Type 2 patients, requiring an extremely simple to use and very convenient and secured insulin delivery patch. By using its JewelPUMP platform, which is already in the industrialization phase and in preparation for the CE marking, Debiotech will be able to introduce the JewelPUMP2 shortly after its JewelPUMP for Type 1 patients, while ensuring the same degree of miniaturization, safety and reliability. The JewelPUMP2 is opening entirely new possibilities for Diabetic Type 2 patients, including improved convenience of use, very easy programming with simplified basal-bolus selection and automatic Meal correction, as well as real-time remote communication and assistance to assist in proper treatment compliance.

Debiotech S.A. and AWAK Technologies Pte Ltd Enter into Joint Agreement for the Development and Manufacturing of a Novel Miniaturized Home Hemodialysis Machine

Debiotech SA, Switzerland, and AWAK Technologies Pte Ltd. announced that they have entered into a partnership agreement regarding the development and manufacturing of a novel miniaturized Home Hemodialysis machine intended to serve the growing need for homecare treatment of patients suffering from end-stage renal disease. This new system will be based on Debiotech's highly miniaturized Home dialysis equipment 'DialEase([TM])', developed for Home Peritoneal dialysis, and AWAK's novel sorbent technology for fluid purification. The combination of both companies' product expertise will lead to a new system which shall be extremely small and convenient to use, less intrusive in a patient's life and more cost effective. This new system will also require much less fluid than conventional Hemodialysis machines and will be monitored in real time from the hospital via the cloud.

Similar Private Companies By Industry

Company Name Region
SPD Swiss Precision Diagnostics GmbH Europe
B. Braun Medical AG Europe
Socorex Isba S.A. Europe
Medaxis AG Europe
Medlight SA Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Debiotech S.A., please visit www.debiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.